Ca2+/Calmodulin-Dependent Protein Kinase II Regulation by Inhibitor of Receptor Interacting Protein Kinase 3
Yuyun Hua1, Jianan Qian1, Ji Cao1
1School of Pharmacy, Nantong University, Nantong 226001, China.
Abstract:
Necroptosisis a regulatory programmed form of necrosis. Receptor interacting protein kinase 3 (RIPK3) is a robust indicator of necroptosis. RIPK3 mediates myocardial necroptosis through activation of calcium/calmodulin-dependent protein kinase II (CaMKII) in cardiac ischemia-reperfusion (I/R) injury and heart failure. However, the exact mechanism of RIPK3 in advanced glycation end products (AGEs)-induced cardiomyocytes necroptosis is not clear. In this study, cardiomyocytes were subjected to AGEs stimulation for 24 h. RIPK3 expression, CaMKII expression, and necroptosis were determined in cardiomyocytes after AGEs stimulation. Then, cardiomyocytes were transfected with RIPK3 siRNA to downregulate RIPK3 followed by AGEs stimulation for 24 h. CaMKIIδ alternative splicing, CaMKII activity, oxidative stress, necroptosis, and cell damage were detected again. Next, cardiomyocytes were pretreated with GSK'872, a specific RIPK3 inhibitor to assess whether it could protect cardiomyocytes against AGEs stimulation. We found that AGEs increased the expression of RIPK3, aggravated the disorder of CaMKII δ alternative splicing, promoted CaMKII activation, enhanced oxidative stress, induced necroptosis, and damaged cardiomyocytes. RIPK3 downregulation or RIPK3 inhibitor GSK'872 corrected CaMKIIδ alternative splicing disorder, inhibited CaMKII activation, reduced oxidative stress, attenuated necroptosis, and improved cell damage in cardiomyocytes.
Insights
Advanced glycation end products (AGEs) induce cardiomyocyte necroptosis via RIPK3 and CaMKII signaling. Inhibiting Receptor interacting protein kinase 3 (RIPK3) protects against AGEs-induced cell damage and necroptosis.
Area of Science:
- Cardiovascular Biology
- Cellular Necrosis
- Molecular Mechanisms
Background:
- Necroptosis is a regulated form of necrosis crucial in cardiac injury.
- Receptor interacting protein kinase 3 (RIPK3) is a key mediator of necroptosis.
- The role of RIPK3 in advanced glycation end products (AGEs)-induced cardiomyocyte necroptosis remains unclear.
Purpose of the Study:
- To elucidate the mechanism of RIPK3 in AGEs-induced cardiomyocyte necroptosis.
- To investigate the involvement of calcium/calmodulin-dependent protein kinase II (CaMKII) in this process.
- To evaluate the protective effects of RIPK3 inhibition against AGEs-induced damage.
Main Methods:
- Cardiomyocytes were stimulated with AGEs.
- RIPK3 expression was modulated using siRNA and a specific inhibitor (GSK'872).
- CaMKII activity, alternative splicing, oxidative stress, necroptosis, and cell damage were assessed.
Main Results:
- AGEs increased RIPK3 expression, CaMKII activation, oxidative stress, and cardiomyocyte necroptosis and damage.
- RIPK3 downregulation or inhibition corrected CaMKIIδ alternative splicing, reduced CaMKII activation, and attenuated oxidative stress.
- RIPK3 inhibition protected cardiomyocytes against AGEs-induced necroptosis and cell damage.
Conclusions:
- RIPK3 plays a critical role in AGEs-induced cardiomyocyte necroptosis.
- AGEs-induced necroptosis involves CaMKII dysregulation and oxidative stress.
- Targeting RIPK3 may offer a therapeutic strategy for AGEs-related cardiovascular complications.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
cAMP-dependent Protein Kinase Pathways
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
GPCRs Regulate Adenylyl Cylase Activity
GPCR Desensitization
G-Protein Gated Ion Channels
Sensory...
